Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival

被引:181
作者
Grant, S
Qiao, L
Dent, P [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiat Oncol, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Hematol Oncol, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2002年 / 7卷
关键词
signal transduction; cell cycle; ErbB1; EGF receptor; ErbB2; tyrphostin; mitogen activated protein kinase (MAPK); c-jun NH2-terminal kinase (JNK); phosphatidyl inositol 3-kinase (PI3K); cyclin kinase inhibitor protein (CKI); p21(Cip-1/WAF1/mda6); apoptosis; caspase; mitochondria; review;
D O I
10.2741/grant
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Within the last 20 years, multiple novel intracellular signal transduction pathways, downstream of plasma membrane receptors, have been discovered. These pathways have been linked to the regulation of diverse cellular events such as proliferation, senescence, differentiation and apoptosis. This review will focus upon the roles of signaling by the ErbB receptor tyrosine kinase family (ErbB1-4) in the survival of cells in response to cytotoxic stresses. In addition, plasma membrane-to-nucleus signaling pathways downstream of these receptors, such as mitogen activated protein kinase (MAPK) and phosphatidyl inositol 3-kinase (PI3K), in the control of cell survival will be discussed. Recent evidence suggests that signaling by the MAPK and PI3K pathways can both enhance proliferation as well as protect cells from apoptosis. We describe potential mechanisms by which modulation of pathway activities following inhibition of ErbB receptor function may alter the sensitivity of cells to toxic insults, leading to increased apoptosis and loss of clonogenic survival.
引用
收藏
页码:D376 / D389
页数:14
相关论文
共 166 条
[21]  
Bruns CJ, 2000, CANCER RES, V60, P2926
[22]   Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer [J].
Burstein, HJ ;
Kuter, I ;
Campos, SM ;
Gelman, RS ;
Tribou, L ;
Parker, LM ;
Manola, J ;
Younger, J ;
Matulonis, U ;
Bunnell, CA ;
Partridge, AH ;
Richardson, PG ;
Clarke, K ;
Shulman, LN ;
Winer, EP .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2722-2730
[23]   Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase [J].
Cai, H ;
Smola, U ;
Wixler, V ;
EisenmannTappe, I ;
DiazMeco, MT ;
Moscat, J ;
Rapp, U ;
Cooper, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (02) :732-741
[24]   Localization and modulation of ErbB receptor tyrosine kinases [J].
Carraway, KL ;
Sweeney, C .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (02) :125-130
[25]   Involvement of the neuregulins and their receptors in cardiac and neural development [J].
Carraway, KL .
BIOESSAYS, 1996, 18 (04) :263-266
[26]   Regulation of Akt/PKB activation by tyrosine phosphorylation [J].
Chen, RY ;
Kim, O ;
Yang, JB ;
Sato, K ;
Eisenmann, KM ;
McCarthy, J ;
Chen, HG ;
Qiu, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31858-31862
[27]   Specific binding of the c-terminal src homology 2 domain of the p85α subunit of phosphoinositide 3-kinase to phosphatidylinositol 3,4,5-trisphosphate -: Localization and engineering of the phosphoinositide-binding motif [J].
Ching, TT ;
Lin, HP ;
Yang, CC ;
Oliveira, M ;
Lu, PJ ;
Chen, CS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (47) :43932-43938
[28]  
Chow NH, 2001, CLIN CANCER RES, V7, P1957
[29]   FUNCTIONAL MAPPING OF THE N-TERMINAL REGULATORY DOMAIN IN THE HUMAN RAF-1 PROTEIN-KINASE [J].
CHOW, YH ;
PUMIGLIA, K ;
JUN, TH ;
DENT, P ;
STURGILL, TW ;
JOVE, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :14100-14106
[30]   Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human cancer cell lines [J].
Ciardiello, F ;
Caputo, R ;
Troiani, T ;
Borriello, G ;
Kandimalla, ER ;
Agrawal, S ;
Mendelsohn, J ;
Bianco, AR ;
Tortora, G .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (02) :172-178